Women with ovarian cancer may be able to stave off relapses for an extra half-year or so by taking a drug already approved to treat kidney cancer, researchers reported Saturday. But it will not be clear whether the drug prolongs women's lives until the patients are followed longer.
Drug used to treat kidney cancer may hold off relapses of ovarian cancer
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You
Sponsored Content